HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Ménard Selected Research

Marginal Zone B-Cell Lymphoma (MALT Lymphoma)

2/2000Detection of aberrant isotype switch recombination in low-grade and high-grade gastric MALT lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Ménard Research Topics

Disease

17Neoplasms (Cancer)
05/2014 - 01/2000
15Breast Neoplasms (Breast Cancer)
08/2013 - 01/2000
3Necrosis
06/2004 - 06/2002
2Carcinoma (Carcinomatosis)
05/2004 - 01/2000
1Dysbiosis
10/2018
1Inflammation (Inflammations)
10/2018
1Colitis
10/2018
1Hypersensitivity (Allergy)
10/2018
1Fetal Macrosomia
02/2017
1Cardiotoxicity
08/2013
1Neoplasm Metastasis (Metastasis)
08/2013
1Disease Progression
08/2013
1Human Influenza (Influenza)
01/2004
1Porcine Reproductive and Respiratory Syndrome (PRRS)
06/2003
1Mucositis
12/2001
1Drug-Related Side Effects and Adverse Reactions
12/2001
1Prostatic Neoplasms (Prostate Cancer)
11/2001
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2001
1Carcinogenesis
10/2000
1Lung Neoplasms (Lung Cancer)
10/2000
1Tuberculosis (Tuberculoses)
07/2000
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2000

Drug/Important Bio-Agent (IBA)

4TamoxifenFDA LinkGeneric
01/2001 - 01/2000
3Interleukin-12 (IL 12)IBA
05/2004 - 07/2000
3Proteins (Proteins, Gene)FDA Link
04/2002 - 01/2000
3Biological ProductsIBA
01/2001 - 02/2000
3Hormones (Hormone)IBA
01/2001 - 01/2000
2Trastuzumab (Herceptin)FDA Link
05/2014 - 08/2013
2Estrogen ReceptorsIBA
08/2013 - 10/2000
2Progesterone Receptors (Progesterone Receptor)IBA
10/2008 - 06/2002
2OligonucleotidesIBA
02/2008 - 06/2003
2Biomarkers (Surrogate Marker)IBA
02/2008 - 01/2001
2Peptides (Polypeptides)IBA
06/2005 - 10/2000
2Oncogene Proteins (Oncogene Protein)IBA
12/2004 - 02/2000
2AntigensIBA
06/2003 - 10/2000
2Monoclonal AntibodiesIBA
04/2002 - 10/2000
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2001 - 02/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2001 - 02/2000
2Fluorouracil (Carac)FDA LinkGeneric
01/2001 - 02/2000
2Paclitaxel (Taxol)FDA LinkGeneric
01/2001 - 02/2000
2Methotrexate (Mexate)FDA LinkGeneric
01/2001 - 02/2000
1Interleukin-10 (Interleukin 10)IBA
10/2018
1Bile Acids and Salts (Bile Acids)IBA
10/2018
1ProstaglandinsIBA
02/2017
1Pharmaceutical PreparationsIBA
08/2013
1Taxoids (Taxanes)IBA
10/2008
1Estrogens (Estrogen)FDA Link
10/2008
1Complementary DNA (cDNA)IBA
02/2008
1Messenger RNA (mRNA)IBA
03/2006
1laminin 1IBA
06/2005
1Laminin (Merosin)IBA
06/2005
1Peptide Hydrolases (Proteases)FDA Link
06/2005
1Tissue Inhibitor of Metalloproteinase-2IBA
06/2005
1matrigelIBA
06/2005
1Laminin ReceptorsIBA
06/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2004
1Conditioned Culture MediaIBA
06/2004
1Lactic Acid (Lactate)FDA LinkGeneric
06/2004
1InterferonsIBA
05/2004
1CPG-oligonucleotideIBA
05/2004
1InterleukinsIBA
05/2004
1Topotecan (Hycamtin)FDA LinkGeneric
05/2004
1ORALIT (ORS)IBA
01/2004
1Pattern Recognition ReceptorsIBA
06/2003
1GuanosineIBA
06/2003
1CytosineIBA
06/2003
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2001
1CytokinesIBA
11/2001
1DNA (Deoxyribonucleic Acid)IBA
11/2001
1FenretinideIBA
02/2001
1Indicators and Reagents (Reagents)IBA
01/2001
1Class 4 Receptor-Like Protein Tyrosine PhosphatasesIBA
10/2000
16-pyruvoyltetrahydropterin synthase (PTPS)IBA
10/2000
1AcetoneIBA
10/2000
1AcidsIBA
10/2000
1MucinsIBA
10/2000
1VaccinesIBA
07/2000
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2000
1Nerve Growth Factor (NGF)IBA
02/2000
1Immunoglobulins (Immunoglobulin)IBA
02/2000
1AntibodiesIBA
02/2000
1Tyrosine Kinase InhibitorsIBA
02/2000

Therapy/Procedure

6Therapeutics
08/2013 - 02/2000
4Drug Therapy (Chemotherapy)
10/2008 - 01/2001
1Immunotherapy
05/2004
1Radical Mastectomy
01/2001
1Chemoprevention
01/2000